 |
Information You Should Know About HUMIRA® (adalimumab)
HUMIRA is a medicine called a Tumor Necrosis Factor (TNF) blocker. HUMIRA is used
to:
- Reduce the signs and symptoms of:
- moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone
or with methotrexate or with certain other medicines. HUMIRA may prevent further
damage to your bones and joints and may help your ability to perform daily activities.
- moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children
4 years of age and older. HUMIRA can be used alone or with methotrexate or with
certain other medicines.
- psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with certain other
medicines. HUMIRA may prevent further damage to your bones and joints and may help
your ability to perform daily activities.
- ankylosing spondylitis (AS) in adults.
- moderate to severe Crohn’s disease (CD) in adults who have not responded well to
conventional treatments. HUMIRA is also for these adults who have lost response
or are unable to tolerate infliximab.
- Treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in
adults who have the condition in many areas of their body and who may benefit from
taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet
light alone or with pills).
Important Safety Information you should know about HUMIRA® (adalimumab).
Serious infections have happened in patients receiving HUMIRA. These infections include TB (tuberculosis) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections.
Before starting HUMIRA:
Tell your doctor if you think you have an infection, are being treated for an infection,
have signs of an infection (such as a fever, cough, or flu-like symptoms), have
any open sores on your body, have warm, red, or painful skin, get a lot of infections
or have infections that keep coming back, have or had hepatitis B infection, take
the medicine Kineret (anakinra), have TB or have been in close contact with someone
who has TB, have lived in an area where TB or histoplasmosis is common, or were
born in, lived in or traveled where there is more risk for getting TB. Your doctor
should test you for TB before starting HUMIRA. If your doctor prescribes any medicine
for the treatment of TB, you should start taking it before starting HUMIRA and take
the full course of TB medicine prescribed.
Tell your doctor if you have any numbness or tingling, or have a disease that affects
your nervous system such as multiple sclerosis or Guillian-Barré syndrome, have
heart failure or other heart conditions, are scheduled for major surgery, are pregnant,
become pregnant, plan to become pregnant or are breastfeeding. Tell your doctor
if you are allergic to HUMIRA or any of its ingredients or are allergic to rubber
or latex. The needle cover of the prefilled syringe and the pen contain dry natural
rubber.
Also, tell your doctor if you have recently received or are scheduled for any vaccines.
Except for live vaccines, patients may still receive vaccines while on HUMIRA. It
is recommended that children with juvenile idiopathic arthritis be brought up to
date with all immunizations prior to starting HUMIRA.
After starting HUMIRA:
Call your doctor right away if you get an infection, or any sign of an infection
including a fever, feeling very tired, cough, flu-like symptoms, warm, red or painful
skin or if you have any open sores on your body. HUMIRA can make you more likely
to get infections or make any infection that you may have worse.
Possible side effects of HUMIRA:
Serious side effects, which sometimes lead to death, have happened in patients taking
HUMIRA.
- Serious infections. These infections include TB (tuberculosis)
and infections caused by viruses, fungi, or bacteria. Your doctor will examine you
for TB and perform a test to see if you have TB. If your doctor feels that you are
at risk for TB, you may be treated with medicine for TB before you begin treatment
with HUMIRA and during treatment with HUMIRA. Even if your TB test is negative your
doctor should carefully monitor you for TB infections while you are taking HUMIRA.
Patients who had a negative TB skin test before receiving HUMIRA have developed
active TB. Tell your doctor if you have any of the following symptoms while taking
or after taking HUMIRA: cough, low-grade fever, weight loss, or loss of body fat
and muscle.
- Certain types of cancer. There have been cases of certain kinds
of cancer in patients taking HUMIRA or other TNF blockers. Patients with RA, especially
more serious RA, may have a higher chance for getting a kind of cancer called lymphoma.
Some patients receiving HUMIRA have developed types of cancer called non-melanoma skin cancer (basal cell
cancer and squamous cell cancer of the skin), which are generally not life threatening
if treated. Tell your doctor if you have a bump or open sore that doesn’t heal.
- Allergic reactions. Signs of a serious allergic reaction include
skin rash, a swollen face, or trouble breathing.
- Hepatitis B virus reactivation in patients that carry the virus in their
blood. Tell your doctor if you have any of the following symptoms: feel
unwell, poor appetite, fatigue, fever, rash or joint pain.
- Nervous system problems. Signs and symptoms include: numbness or
tingling, problems with your vision, weakness in your arms or legs, and dizziness.
- Blood problems. Symptoms include a fever that does not go away,
bruising or bleeding very easily, or looking very pale.
- New heart failure or worsening heart failure you already have.
Symptoms include shortness of breath or swelling of your ankles or feet, or sudden
weight gain.
- Immune reactions including a lupus-like syndrome. Symptoms include
chest discomfort or pain that does not go away, shortness of breath, joint pain,
or rash on your cheeks or arms that gets worse in the sun.
Call your doctor or get medical care right away if you develop any of the above symptoms.
Your treatment with HUMIRA may be stopped.
Common side effects of HUMIRA are: injection site reactions (redness,
rash, swelling, itching or bruising), upper respiratory infections (sinus infections),
headaches, rash and nausea.
These are not all the side effects with HUMIRA. Ask your doctor or pharmacist for
more information.
Please see the Medication Guide for HUMIRA and discuss it with your doctor.
64S-108806
|
 |